0001381825-11-000001.txt : 20110523 0001381825-11-000001.hdr.sgml : 20110523 20110523140536 ACCESSION NUMBER: 0001381825-11-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110523 DATE AS OF CHANGE: 20110523 EFFECTIVENESS DATE: 20110523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CELL BIOSCIENCES INC CENTRAL INDEX KEY: 0001381825 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-160197 FILM NUMBER: 11864466 BUSINESS ADDRESS: STREET 1: 3040 OAKMEAD VILLAGE DRIVE CITY: CUPERTINO STATE: CA ZIP: 94304 BUSINESS PHONE: 408 510-5500 MAIL ADDRESS: STREET 1: 3040 OAKMEAD VILLAGE DRIVE CITY: CUPERTINO STATE: CA ZIP: 94304 D 1 primary_doc.xml X0704 D LIVE 0001381825 CELL BIOSCIENCES INC 3040 OAKMEAD VILLAGE DRIVE CUPERTINO CA CALIFORNIA 94304 408 510-5500 DELAWARE Signal Analytics, Inc. None Corporation true Timothy Harkness c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA CALIFORNIA 95051 Executive Officer Director David Barker c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA CALIFORNIA 95051 Director A. Blaine Bowman c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA CALIFORNIA 95051 Director Ron Eastman c/o Essex Woodlands Health Ventures 335 Bryant Street, 3rd Floor Palo Alto CA CALIFORNIA 94301 Director Jack Nielson c/o Novo A/S Krogshoejvej 41 Bagsvaerd G7 DENMARK DK 2880 Director James Woody c/o Latterell Venture Partners 1 Embarcadero Center, Suite 4050 San Francisco CA CALIFORNIA 94111 Director Jason Novi c/o Cell Biosciences, Inc. 3040 Oakmead Village Drive Santa Clara CA CALIFORNIA 95051 Executive Officer Biotechnology Decline to Disclose 06 false 2011-05-11 false true true true true Offering of Series F Preferred Stock ("Series F"), warrants to purchase Common Stock ("Warrants") and the underlying shares of Common Stock isuable upon conversion of the Series F and upon exercise of Warrants. true The Issuer used approximately $9,000,000 of the total amount sold in the offering to purchase all of the outstanding shares of Brightwell Technologies, Inc. 0 13000866 13000866 0 false 14 0 0 0 false CELL BIOSCIENCES INC /s/ Timothy Harkness Timothy Harkness President and CEO 2011-05-23